The results showed that rabbits with atherosclerosis presented higher IL-6, IL-1β, IFN-γ and TNF-α levels than those in the control group; however, ruxolitinib substantially decreased IL-6, IL-1β, IFN-γ and TNF-α contents in rabbits with atherosclerosis. Here, IFNG is linked to atherosclerosis.